Evaluacija kliničkih i biohemijskih parametara hospitaliziranih COVID-19 pacijenata -retrospektivna studija iz Bosne i Hercegovine
Sažetak
For the first time, to evaluate and present the socio-demographic and clinical manifestations, laboratory findings, and outcomes of hospitalized Coronavirus Disease 2019 (COVID-19) patients from Canton Sarajevo, Bosnia and Herzegovina. This retrospective, single-centre study included 159 RT-PCR verified COVID-19 patients (92 mild/moderate and 67 severe/critical) consecutively hospitalized at the General Hospital "Prim. dr Abdulah Nakaš" in Sarajevo, Bosnia and Herzegovina. Socio-demographic, clinical, and laboratory data on admission were retrospectively obtained from each patient's electronic medical record and patient files by two experienced physicians.
The study was conducted from November 1st, 2020 to March 15th, 2021. Most of the patients (43.4%) belonged to the age range of 46 - 65 years; 71.1% were men, and 68.6% had comorbidities. Among the patients who had comorbidities, hypertension was the most prevalent comorbidity (100%), followed by diabetes (91.7%), and ischemic heart disease (35.8%). The leading clinical symptoms were fever (87.44%), tiredness (77.8%), and body/muscle aches (73%). There was significant reduction of blood oxygen saturation (p=0.005), and significant elevation of D-dimer (p=0.003), CRP (p=0.044), and fasting plasma glucose (p=0.047) in the severe/critical patients group compared to mild/moderate group.
Older age, the male gender, confirmed comorbidities, decreased blood oxygen saturation, increased levels of CRP, D-dimer, and fasting plasma glucose, together with symptoms of chest pain/shortness of breath and/or diarrhea occurred more frequently in severe/critical than mild/moderate COVID-19 and contributed to adverse outcomes.
Reference
2. Lai CC, Shih,TP, Ko WC, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents 2020; 55(3), 105924. http://doi.org/10.1016/j.ijantimicag.2020.105924.
3. Nowak B, Szymański P, Pańkowski I, et al. Clinical characteristics and short-term outcomes of patients with coronavirus disease 2019: a retrospective single-center experience of a designated hospital in Poland. Polish Archive of Internal Medicine 2020; 130(5), 407-11. http://doi.org/10.20452/pamw.15361.
4. Espiritu AI, Sy M, Anlacan V, et al. The Philippine COVID-19 outcomes: a retrospective study of neurological manifestations and associated symptoms (The Philippine CORONA study): a protocol study. BMJ Open. 2020; 10(11), e040944. http://doi.org/10.1136/bmjopen-2020-040944.
5. Zaim S, Chong JH, Sankaranarayanan V, et al. COVID-19 and multiorgan response. Current Poblems in Cardiology 2020; 45(8), 100618. http://doi.org/10.1016/j.cpcardiol.2020.100618.
6. Pajević I, Hasanović M, Avdibegović E, et al. Organization of mental healthcare in Bosnia and Herzegovina during coronavirus disease 2019 pandemic. Indian Journal of Psychiatry 2020; 62(3), 479-91. http://doi.org/10.4103/psychiatry.IndianJPsychiatry_1044_20.
7. Jogunčić A, Pilav A, Bajramović A, et al. Canton Sarajevo journey through COVID-19 pandemic. Journal of Health Science 2020; 10(3), 176-82. http://doi.org/10.17532/jhsci.2020.1031.
8. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/region/euro/country/ba (02 April 2021, date last accessed).
9. World Health Organization. Laboratory testing for coronavirus disease 2019 (COVID 19) in suspected human cases: interim guidance, 2 March 2020.
10. Liao X, Wang B, Kang Y. Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China. Intensive Care Medicine 2020; 46(2), 357-60. http://doi.org/10.1007/s00134-020-05954-2.
11. Popov GT, Baymakova M, Vaseva V, et al. Clinical characteristics of hospitalized patients with COVID-19 in Sofia, Bulgaria. Vector-Borne and Zoonotic Diseases 2020; 20(12), 910-15. http://doi.org/10.1089/vbz.2020.2679.
12. Conti P, Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. Journal of Biological Regulators and Homeostatic Agents. 2020; 34(2), 339-43. http://doi.org/10.23812/Editorial-Conti-3.
13. Ghweil AA, Hassan MH, Khodeary A, et al. Characteristics, outcomes and indicators of severity for COVID-19 among sample of ESNA quarantine hospital's patients, Egypt: A retrospective study. Infection and Drug Resistance 2020; 3, 2375-83. http://doi.org/10.2147/IDR.S263489.
14. Liu K, Chen Y, Lin R, et al. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. Journal of Infection 2020; 80(6), 14-18. http://doi.org/10.1016/j.jinf.2020.03.005.
15. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020; 395(10229), 1054-62. http://doi.org/10.1016/S0140-6736(20)30566-3.
16. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11), 1061-69. http://doi.org/10.1001/jama.2020.1585.
17. Klein S, Pekosz A, Park HS, et al. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. Journal of Clinical Investigation 2020; 130(11), 6141-50. http://doi.org/10.1172/JCI142004.
18. Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. Journal of Infection 2020; 80(6), 656-65. http://doi.org/10.1016/j.jinf.2020.03.041.
19. Trigo J, García-Azorín D, Planchuelo-Gómez Á, et al. Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study. The Journal of Headache and Pain 2020; 21(1), 94. http://doi.org/10.1186/s10194-020-01165-8.
20. Islam MA, Alam SS, Kundu S, et al. Prevalence of headache in patients with Coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 14.275 patients. Frontiers in Neurology 2020; 11, 562634. http://doi.org/10.3389/fneur.2020.562634.
21. Emami A, Javanmardi F, Pirbonyeh N, et al. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Archives of Academic Emergency Medicine 2020; 8(1), e35.
22. Cekerevac I, Turnic TN, Draginic N, et al. Predicting severity and intrahospital mortality in COVID-19: The place and role of oxidative stress. Oxidative Medicine and Cellular Longevity 2021; 26, 6615787. http://doi.org/10.1155/2021/6615787.
23. Wu Y, Potempa LA, El Kebir D, et al. C-reactive protein and inflammation: conformational changes affect function. Biological Chemistry 2015; 396(11), 1181-97. http://doi.org/10.1515/hsz-2015-0149.
24. Zhang Y, Zheng L, Liu L, et al. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver International 2020; 40(9), 2095-103. http://doi.org/10.1111/liv.14455.
25. Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020; 369, m1966. http://doi.org/10.1136/bmj.m1966.
26. Kuo T, McQueen A, Chen TC, et al. Regulation of glucose homeostasis by glucocorticoids. Advances in Experimental Medicine and Biology 2015; 872, 99-126. http://doi.org/10.1007/978-1-4939-2895-8_5.
27. Mazinani M, Rude BJ. The novel zoonotic Coronavirus disease 2019 (COVID-19) pandemic: Health perspective on the outbreak. Journal of Healthcare Quality Research 2021; 36(1), 47-51. http://doi.org/10.1016/j.jhqr.2020.09.004.
28. Mejía F, Medina C, Cornejo E, et al. Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. PloS One 2020; 15(12), e0244171. http://doi.org/10.1371/journal.pone.0244171.
29. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England). 2020; 395(10223), 507-513. http://doi.org/10.1016/S0140-6736(20)30211-7.
30. Medetalibeyoglu A, Catma Y, Senkal N, et al. The effect of liver test abnormalities on the prognosis of COVID-19. Annaled of Hepatology 2020; 19(6), 614-21. http://doi.org/10.1016/j.aohep.2020.08.068.
31. Zinellu A, De Vito A, Scano V, et al. The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients. Journal of Infection in Developing Countries 2021; 15(3), 353-59. http://doi.org/10.3855/jidc.13288.
32. Biswas M, Rahaman S, Biswas TK, et al. Association of sex, age, and comorbidities with mortality in COVID-19 patients: A systematic review and meta-analysis. International Virology 2020; 1-12. http://doi.org/10.1159/000512592.
